<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: How to Write a Business Plan</title>
	<atom:link href="http://www.damienbove.com/how-to-write-a-business-plan/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.damienbove.com</link>
	<description>Damien Bove Shares The Expertise</description>
	<lastBuildDate>Mon, 23 Jan 2012 10:28:05 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Device Regulators, MHRA, Publish Draft for Comment on Vigilance Systems for CE-Marked Medical Devices - Cardiac Ablation Catheters. &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-7356</link>
		<dc:creator>Device Regulators, MHRA, Publish Draft for Comment on Vigilance Systems for CE-Marked Medical Devices - Cardiac Ablation Catheters. &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Sat, 06 Mar 2010 11:30:29 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-7356</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Drug Regulators, FDA, Publish Draft Guidance on Adaptive Design Clinical Trials for Drugs and Biologicals. &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-7283</link>
		<dc:creator>Drug Regulators, FDA, Publish Draft Guidance on Adaptive Design Clinical Trials for Drugs and Biologicals. &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Thu, 04 Mar 2010 10:23:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-7283</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Drug Regulators, FDA, Publish Draft Guidance for Industry, Non-Inferiority Clinical Trials &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-7182</link>
		<dc:creator>Drug Regulators, FDA, Publish Draft Guidance for Industry, Non-Inferiority Clinical Trials &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Tue, 02 Mar 2010 10:14:49 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-7182</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Drug Regulators, EMEA (EMA), Publish Draft Guidance on the Investigation of Bioequivalence. &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-7145</link>
		<dc:creator>Drug Regulators, EMEA (EMA), Publish Draft Guidance on the Investigation of Bioequivalence. &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Mon, 01 Mar 2010 10:49:28 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-7145</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Drug Regulators, MHRA, Publish Consultation Document on ARM 65 Algopain-EZE 140MG Medicated Plaster, Request to Reclassify a Prodcut from POM to P &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-7060</link>
		<dc:creator>Drug Regulators, MHRA, Publish Consultation Document on ARM 65 Algopain-EZE 140MG Medicated Plaster, Request to Reclassify a Prodcut from POM to P &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Sat, 27 Feb 2010 10:43:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-7060</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Drug Regulators, EMA (EMEA), Publish draft guidance on Clinical Investigations in the Treatment of Diabetes Mellitus &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-7014</link>
		<dc:creator>Drug Regulators, EMA (EMEA), Publish draft guidance on Clinical Investigations in the Treatment of Diabetes Mellitus &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Fri, 26 Feb 2010 10:41:31 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-7014</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: regulators EMEA (EMA), Publish a Concept Paper on the Need For Guidance on Clinical Investigations of Medicinal Products in the Treatment of Diabetes Mellitus &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-6982</link>
		<dc:creator>regulators EMEA (EMA), Publish a Concept Paper on the Need For Guidance on Clinical Investigations of Medicinal Products in the Treatment of Diabetes Mellitus &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Thu, 25 Feb 2010 10:33:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-6982</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Drug Regulators, FDA, Publish Guidance For Industry on Content of a Complete Submission for the Evaluation of Proprietary Names. &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-6795</link>
		<dc:creator>Drug Regulators, FDA, Publish Guidance For Industry on Content of a Complete Submission for the Evaluation of Proprietary Names. &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Wed, 17 Feb 2010 11:08:44 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-6795</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Drug Regulators, EMEA, Publish Addendum to the Note for Guidance on Evaluation of Medicinal Products Indicated for the Treatment of Bacterial Infections &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-6778</link>
		<dc:creator>Drug Regulators, EMEA, Publish Addendum to the Note for Guidance on Evaluation of Medicinal Products Indicated for the Treatment of Bacterial Infections &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Tue, 16 Feb 2010 11:07:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-6778</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Drug Regulators, EMEA, Publish an Overview of Comments Received on Draft Guidance on Clinical Investigations of Medicinal Products Used in Osteoarthritis &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/how-to-write-a-business-plan/comment-page-3/#comment-6762</link>
		<dc:creator>Drug Regulators, EMEA, Publish an Overview of Comments Received on Draft Guidance on Clinical Investigations of Medicinal Products Used in Osteoarthritis &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Mon, 15 Feb 2010 11:00:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=632#comment-6762</guid>
		<description>[...] How to Write a Business Plan [...]</description>
		<content:encoded><![CDATA[<p>[...] How to Write a Business Plan [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

